In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.
- InMed does not grow cannabis. We biosynthesize the compounds in a lab.
- InMed products do not contain THC.
- InMed products are applied topically.
In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.

Article featured in Fierce Biotech October 16, 2025 Excerpt: New findings discussed at the latest Alzheimer’s Association International Conference (AAIC) highlight the risk factors associated

Video Replay Now Available: InMed’s CEO, Eric A. Adams, presents at the 2025 Life Sciences Investor Forum. In the presentation, which was originally published on

InMed presented data from its INM-901 Alzheimer’s disease program at the 2025 Alzheimer’s Association International Conference held in Toronto, Canada. The latest study presented in
"*" indicates required fields